Stay updated on Pembrolizumab in Triple Negative Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Triple Negative Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Triple Negative Breast Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    New navigation and help sections were added (No longer looking for participants, How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment heading was updated. The revision tag was updated to Revision: v3.6.0 and the older Revision: v3.5.5 note was removed.
    Difference
    0.4%
    Check dated 2026-06-12T16:38:38.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.5.4 to v3.5.5, signaling a maintenance update to the page without described user-facing changes.
    Difference
    0.1%
    Check dated 2026-06-05T12:31:23.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    The page footer displays Revision: v3.5.4, replacing the previous v3.5.3. This indicates the page content has been updated to a newer revision.
    Difference
    0.1%
    Check dated 2026-05-15T04:50:33.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.5.2 to v3.5.3, representing a newer version of the ClinicalTrials.gov page. There are no changes described to the study details, eligibility, or outcomes in this change.
    Difference
    0.1%
    Check dated 2026-04-30T18:30:42.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    The website revision has been updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-16T10:44:09.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    No substantive study information was added or removed. The visible differences appear to be formatting or UI updates rather than content changes.
    Difference
    0.1%
    Check dated 2026-04-02T00:32:20.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Triple Negative Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Triple Negative Breast Cancer Clinical Trial page.